
Human Ephrin type-A receptor 2 550-558, VLAGVGFFI
Description
About Human Ephrin type-A receptor 2 550-558, VLAGVGFFI
The Human Ephrin type-A receptor 2 Peptide (IEDB: 2188957) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Ephrin type-A receptor 2 Peptide, H-VLAGVGFFI-OH (Uniprot: P29317 aa: 550-558) from JPT is produced under strict quality control and quality management.
Human Ephrin type-A receptor 2 550-558, VLAGVGFFI - Specifications
- Peptide sequence: H-VLAGVGFFI-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Melanoma
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human Ephrin type-A receptor 2 550-558, VLAGVGFFI
References:
Read References with JPT’s Antigen Peptides
Human Ephrin type-A receptor 2 550-558, VLAGVGFFI has been described in:
Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade., Front Immunol, 2022 (PMID: 35874702)
Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide., Sci Rep, 2019 (PMID: 30850685)
Documentation
Documentation for Human Ephrin type-A receptor 2 550-558, VLAGVGFFI
Properties
Properties of Human Ephrin type-A receptor 2 550-558, VLAGVGFFI
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Melanoma |
Layout: | Freeze-dried in glass vial |
Organism: | Human |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human Ephrin type-A receptor 2 550-558, VLAGVGFFI
Information | Values |
---|---|
Sequence: | H-VLAGVGFFI-OH |
Specifications: | 9mer peptide as TFA salt |